Tools
Search
Import
Library
Explore
Videos
Channels
Figures
Atmrix
About
Tools
Search
Import
Library
Explore
Videos
Channels
Figures
Atmrix
About
Go Back
MJ
Max Jaderberg
04/29/25
@ Sequoia Capital
Drug design is complex, requiring an understanding of how small molecules interact with proteins, modulating their functions in the body.
Video
SC
The Quest to ‘Solve All Diseases’ with AI: Isomorphic Labs’ Max Jaderberg
@ Sequoia Capital
04/29/25
Related Takeaways
MJ
Max Jaderberg
04/29/25
@ Sequoia Capital
Understanding how molecules interact with all proteins in the body is crucial, as this knowledge can help predict toxicity and improve drug design.
MJ
Max Jaderberg
04/29/25
@ Sequoia Capital
Drug design is complex, with numerous bottlenecks before reaching clinical trials, and we need to innovate in this space to improve the process.
MJ
Max Jaderberg
04/29/25
@ Sequoia Capital
AlphaFold 3 enables drug designers to model not just protein structures but also how these proteins interact with small molecules, enhancing our ability to design effective drugs.
MJ
Max Jaderberg
04/29/25
@ Sequoia Capital
Before AlphaFold 3, drug designers had to rely on intuition and lengthy lab processes to understand molecular interactions, which is no longer the case.
MJ
Max Jaderberg
04/29/25
@ Sequoia Capital
To achieve transformative drug design, we need several more breakthroughs similar to AlphaFold, focusing on different core concepts of biology and chemistry.
PH
Patrick Hsu
04/15/25
@ Sequoia Capital
Programming biology goes beyond drug development; it involves understanding how hormones can influence thoughts, feelings, and behaviors in powerful ways.
PH
Patrick Hsu
04/15/25
@ Sequoia Capital
Machine learning for biology is not limited to drug design; it encompasses a broader potential that significantly impacts human lives.
MJ
Max Jaderberg
04/29/25
@ Sequoia Capital
AlphaFold 3 allows our drug designers to see how their molecule designs interact with protein targets instantly, which is a game changer in drug design.
MJ
Max Jaderberg
04/29/25
@ Sequoia Capital
Building a diverse team of experts in AI, chemistry, and biology is essential for questioning traditional approaches and fostering innovation in drug design.